4981|5338|Public
5|$|Some {{are prone}} to {{dislocation}} of the kneecaps, inherited eye diseases, deafness and Legg Perthes—a disease of the hip joints of small dog breeds. Prone to <b>mast</b> <b>cell</b> tumors.|$|E
5|$|Scottish Terriers have {{a greater}} chance of {{developing}} some cancers than other purebreds. According to research by the Veterinary Medical Data Program (1986), six cancers that Scotties appeared to be more at risk for (when compared to other breeds) are: (in descending order) bladder cancer and other transitional cell carcinomas of the lower urinary tract; malignant melanoma; gastric carcinoma; squamous cell carcinoma of the skin; lymphosarcoma and nasal carcinoma. Other cancers that are known to commonly affect Scotties include <b>mast</b> <b>cell</b> sarcoma and hemangiosarcoma.|$|E
5|$|In summary, the Fab {{region of}} the {{antibody}} determines antigen specificity while the Fc {{region of the}} antibody determines the antibody's class effect. Since only the constant domains of the heavy chains make up the Fc region of an antibody, the classes of heavy chain in antibodies determine their class effects. Possible classes of heavy chains in antibodies include alpha, gamma, delta, epsilon, and mu, and they define the antibody's isotypes IgA, G, D, E, and M, respectively. This infers different isotypes of antibodies have different class effects due to their different Fc regions binding and activating different types of receptors. Possible class effects of antibodies include: Opsonisation, agglutination, haemolysis, complement activation, <b>mast</b> <b>cell</b> degranulation, and neutralisation (though this class effect may be mediated by the Fab region rather than the Fc region). It also implies that Fab-mediated effects are directed at microbes or toxins, whilst Fc mediated effects are directed at effector cells or effector molecules (see below).|$|E
40|$|Objective: To {{detect and}} {{quantify}} <b>mast</b> <b>cells</b> in peritoneal, ovarian, and deep infiltrating endometriosis and {{to study the}} relationship between <b>mast</b> <b>cells</b> and nerves in endometriosis. Design: Prospective histological and immunohistochemical study. Setting: University of Brussels, Belgium. Patient(s) : Sixty-nine women undergoing laparoscopic excision of endometriosis for pain. Thirty-seven biopsies of normal tissue were obtained from women without endometriosis. Intervention(s) : Excision of endometriosis from different anatomical locations. Main Outcome Measure(s) : Immunohistochemistry with chymase and tryptase to confirm the presence of <b>mast</b> <b>cells</b> and activated <b>mast</b> <b>cells,</b> respectively, in endometriotic lesions. Quantification of <b>mast</b> <b>cells,</b> activated <b>mast</b> <b>cells,</b> and degranulating <b>mast</b> <b>cells</b> in the different locations of endometriosis. Study {{of the relationship between}} <b>mast</b> <b>cells</b> and nerves by quantifying <b>mast</b> <b>cells</b> located less than 25 μm from nerves immunohistochemically stained with S- 100 protein. Preoperative pain score evaluation by visual analogue scales. Result(s) : Patients with deeply infiltrating lesions had significantly higher preoperative pain scores than patients with peritoneal or ovarian endometriosis. <b>Mast</b> <b>cells</b> and degranulating <b>mast</b> <b>cells</b> are significantly more abundant in endometriotic lesions than in nonaffected tissues. Deep infiltrating lesions show a significantly higher number of <b>mast</b> <b>cells,</b> activated <b>mast</b> <b>cells,</b> and <b>mast</b> <b>cells</b> located < 25 μm from nerves than peritoneal and ovarian lesions. We found significantly more degranulating <b>mast</b> <b>cells</b> in deep infiltrating lesions than in peritoneal lesions. Conclusion(s) : The presence of increased activated and degranulating <b>mast</b> <b>cells</b> in deeply infiltrating endometriosis, which are the most painful lesions, and the close histological relationship between <b>mast</b> <b>cells</b> and nerves strongly suggest that <b>mast</b> <b>cells</b> could {{contribute to the development of}} pain and hyperalgesia in endometriosis, possibly by a direct effect on nerve structures. © 2006 American Society for Reproductive Medicine. SCOPUS: ar. jinfo:eu-repo/semantics/publishe...|$|R
40|$|Background: The {{objective}} {{of this study was}} to assess <b>mast</b> <b>cells</b> and TNF-α in oral lichen planus (OLP) and oral lichenoid reactions (OLR) patients as diagnostic marker to the differential diagnosis of OLP and OLR diseases. Materials and Methods: In this cross-sectional study, samples were obtained from 30 OLP and 30 OLR patients, between June 2010 and March 2011 in Dental clinic of the University of Isfahan, Iran. <b>Mast</b> <b>cells</b> in the reticular layer of the lamina propria for samples were evaluated using toluidine blue method and immunohistochemical technique. The clinical relevant data taken into account were: demographical data, total number and degranulated <b>mast</b> <b>cells,</b> ratio of degranulated <b>mast</b> <b>cells</b> and TNF-α positive degranulated <b>mast</b> <b>cells.</b> Results: In OLP and OLR, the total <b>mast</b> <b>cells</b> were 21. 2 ± 7. 9 and 20. 3 ± 6. 8, degranulated <b>mast</b> <b>cells</b> were 15. 5 ± 6. 9 and 19. 2 ± 6. 9, ratio of degranulated <b>mast</b> <b>cells</b> to total <b>mast</b> <b>cells</b> were 0. 716 ± 0. 067 and 0. 946 ± 0. 081, and TNF-α positive degranulated <b>mast</b> <b>cells</b> were 13. 6 ± 6. 3 and 17. 1 ± 6. 04, respectively. There was no significant difference for the total <b>mast</b> <b>cells.</b> But degranulated <b>mast</b> <b>cells,</b> ratio of degranulated <b>mast</b> <b>cells</b> and TNF-α positive degranulated <b>mast</b> <b>cells</b> in OLR were significantly higher than OLP patients. Conclusions: Our results showed that the degranulated <b>mast</b> <b>cells,</b> ratio of degranulated <b>mast</b> <b>cells</b> and TNF-α in OLR was significantly more than OLP patients and these may be able to be used as diagnostic markers to the differential diagnosis of OLP and OLR...|$|R
50|$|<b>Mast</b> <b>cells</b> in rodents are classically {{divided into}} two subtypes: {{connective}} tissue-type <b>mast</b> <b>cells</b> and mucosal <b>mast</b> <b>cells.</b> The activities of the latter are dependent on T-cells.|$|R
5|$|Antibodies are glycoproteins {{belonging}} to the immunoglobulin superfamily. They constitute most of the gamma globulin fraction of the blood proteins. They are typically made of basic structural units—each with two large heavy chains and two small light chains. There are several different types of antibody heavy chains that define the five different types of crystallisable fragments (Fc) that may {{be attached to the}} antigen-binding fragments. The five different types of Fc regions allow antibodies to be grouped into five isotypes. Each Fc region of a particular antibody isotype is able to bind to its specific Fc Receptor (except for IgD, which is essentially the BCR), thus allowing the antigen-antibody complex to mediate different roles depending on which FcR it binds. The ability of an antibody to bind to its corresponding FcR is further modulated by the structure of the glycan(s) present at conserved sites within its Fc region. The ability of antibodies to bind to FcRs helps to direct the appropriate immune response for each different type of foreign object they encounter. For example, IgE is responsible for an allergic response consisting of <b>mast</b> <b>cell</b> degranulation and histamine release. IgE's Fab paratope binds to allergic antigen, for example house dust mite particles, while its Fc region binds to Fc receptor ε. The allergen-IgE-FcRε interaction mediates allergic signal transduction to induce conditions such as asthma.|$|E
25|$|However, {{there is}} a {{significant}} amount of discordance between veterinary pathologists in assigning grades to <b>mast</b> <b>cell</b> tumors due to imprecise criteria.|$|E
25|$|Frequently seen cancers include lymphoma, melanoma, <b>mast</b> <b>cell</b> tumors (which are {{considered}} to be potentially malignant, even though they may have benign behavior), and osteosarcoma (bone cancer).|$|E
50|$|<b>Mast</b> <b>cells</b> seem to {{have other}} roles as well. Because they gather {{together}} around wounds, <b>mast</b> <b>cells</b> may {{play a part in}} wound healing. For example, the typical itching felt around a healing scab may be caused by histamine released by <b>mast</b> <b>cells.</b> Researchers also think <b>mast</b> <b>cells</b> may have a role in the growth of blood vessels (angiogenesis). No one with too few or no <b>mast</b> <b>cells</b> has been found, which indicates to some scientists {{we may not be able}} to survive with too few <b>mast</b> <b>cells.</b>|$|R
40|$|Mouse <b>mast</b> <b>cells</b> can be {{assigned}} to two subclasses, defined as connective tissue-type, and mucosal-type, <b>mast</b> <b>cells.</b> Mucosal-type <b>mast</b> <b>cells</b> can be distinguished from connective tissue-type <b>mast</b> <b>cells</b> by their anatomical location, histochemical staining properties (1), and T cell dependence for proliferation during a helminthic infection (2). Mouse serosal <b>mast</b> <b>cells</b> (SMC) t, which are connective tissue-type <b>mast</b> <b>cells,</b> express on their surface the neutral glycosphingolipid globopentaosylceramide (which contains the Forssman epitope) (3), and contain in their secretory granules protease-resistant heparin proteoglycans of ^- 750, 400 Mf (4, 5). Although definitive biochemical data are not available, as assessed by their histochemical staining properties (1), mouse intestinal mucosal <b>mast</b> <b>cells</b> contain little or no heparin proteoglycans. In 1981, several laboratories reported (6 - 10) that cells that possessed the phenotypic characteristics of <b>mast</b> <b>cells</b> could be grown from mouse hematopoietic progenitors {{in the presence of}} conditioned medium containing T cellderived soluble factors. These cultured <b>mast</b> <b>cells</b> exhibited a number of similaritie...|$|R
40|$|Purification of <b>mast</b> <b>cells</b> {{from the}} peritoneal cavity of rats and {{reactivity}} {{of the cells}} to antigen were studies. After peritoneal lavage, the peritoneal cells were washed, the <b>mast</b> <b>cells</b> were isolated by a density gradient centrifugation method. The recovery rate of <b>mast</b> <b>cells</b> was highest when <b>mast</b> <b>cells</b> were separated by BSA density gradient centrifugation after washing the cells on time by low speed centrifugation (50 xg). The purity of <b>mast</b> <b>cells</b> obtained by this method was 94. 1 ± 1. 0 %, {{and the number of}} <b>mast</b> <b>cells</b> obtained was approximately 1. 46 × 10 (6) 　cells/rat. <b>Mast</b> <b>cells</b> of actively sensitized rats showed a significant increase in (45) Ca uptake and histamine release after stimulation by antigen. (45) Ca uptake by <b>mast</b> <b>cells</b> of passively sensitized rats was affected by BSA medium, and the most suitable results were obtained using <b>mast</b> <b>cells</b> passively sensitized before separation of the <b>cells</b> by BSA. <b>Mast</b> <b>cells</b> showed a significant increase in (45) Ca uptake after stimulation by various stimulatory agents, such as Con. A, Comp. 48 / 80 and Ca ionophore A 23187. These results indicate that rat peritoneal <b>mast</b> <b>cells</b> isolated by the present method can be used in studies on Ca(2 +) influx into the cells...|$|R
25|$|In the {{allergic}} subtype of disease, it {{is thought}} that food allergens cross the intestinal mucosa and trigger an inflammatory response that includes <b>mast</b> <b>cell</b> degranulation and recruitment of eosinophils.|$|E
25|$|A <b>mast</b> <b>cell</b> tumor (mastocytoma) {{is a type}} of tumor {{normally}} {{found in}} the skin of dogs. It can also invade the subcutis and spread to the liver, spleen, or bone marrow.|$|E
25|$|<b>Mast</b> <b>cell</b> tumors do not {{necessarily}} follow the histological prognosis. Further prognostic information can be provided by AgNOR stain of histological or cytological specimen. Even then, {{there is a risk}} of unpredictable behavior.|$|E
40|$|<b>Mast</b> <b>cells</b> {{may play}} a role in {{rheumatoid}} arthritis (RA), but activation of human <b>mast</b> <b>cells</b> in autoimmune settings has been little studied. Toll-like receptors (TLR) and Fcγ receptors (FcγR) are important receptors for cellular activation in the joint, but expression and stimulation of these receptors in human <b>mast</b> <b>cells</b> or the functional interplay between these pathways is poorly understood. Here, we analysed triggering of human <b>mast</b> <b>cells</b> via these receptors in the context of anti-citrullinated protein antibody-positive (ACPA+) RA. RNA and protein expression of TLRs and FcγR was quantified using PCR and flow cytometry, respectively. <b>Mast</b> <b>cells</b> were stimulated with TLR ligands (including HSP 70) combined with IgG immune complexes and IgG-ACPA. Human <b>mast</b> <b>cells</b> expressed TLRs and produced cytokines in response to TLR ligands. Both cultured and synovial <b>mast</b> <b>cells</b> expressed FcγRIIA, and triggering of this receptor by IgG immune complexes synergised with activation by TLR ligands, leading to two- to fivefold increased cytokine levels. <b>Mast</b> <b>cells</b> produced cytokines in response to ACPA immune complexes in a citrulline-specific manner, which synergised in the presence of HSP 70. Our data show that synovial <b>mast</b> <b>cells</b> express FcγRIIA and that <b>mast</b> <b>cells</b> can be activated by IgG-ACPA and TLR ligands. Importantly, combined stimulation via TLRs and immune complexes leads to synergy in cytokine production. These findings suggest <b>mast</b> <b>cells</b> are important targets for TLR ligands and immune complexes, and that combined activation of <b>mast</b> <b>cells</b> via these pathways greatly enhances inflammation in synovial tissue of RA patient...|$|R
40|$|A). Fluctuation of <b>mast</b> <b>cells</b> {{in blood}} was {{investigated}} following injection of ten per cent of cancer extract in rabbit, and results obtained were as follows. <b>Mast</b> <b>cells</b> were markedly increased after injection of cancer extract, but not after injection of gastric mucosa in peptic ulcer as control. It was, namely, concluded experimentally that the <b>mast</b> <b>cells</b> were increased by the so-called cancer toxin in the extract. B). Fluctuation of <b>mast</b> <b>cells</b> in blood was investigated following injection of Guronsan (glucuronic acid), Moriamin-S (amino-acid) or Tespamin (TSPA) in rabbit, and results obtained were as follows. 1). <b>Mast</b> <b>cells</b> were increased with injection of Guronsan, but decreased after cessation of the injection; Guronsan had increasing effect of <b>mast</b> <b>cells.</b> 2). On the injection of Moriamin-S, {{white blood cells}} were noticeably increased with increase of <b>mast</b> <b>cells</b> in blood, but <b>mast</b> cell: white <b>cell</b> ratio was not so remarkable; Moriamin-S had increasing effect of <b>mast</b> <b>cells.</b> 3). On the injection of Tespamin, white cells were decreased with slight decrease of <b>mast</b> <b>cells</b> in blood. c). Fluctuation of <b>mast</b> <b>cells</b> in blood was investigated after injection of Guronsan, Moriamin-S or Tespamin with each concomitant injection of ten per cent of cancer extract, and results obtained were as follows. 1). On the injections of Guronsan and cancer extract, <b>mast</b> <b>cells</b> in blood were far markedly increased, proving acceleration in the increase. 2). On the injections of Moriamin-S and cancer extract, they were also significantly increased; suppressive effect in the recovery after injection. 3). On the injections of Tespamin and cancer extract, <b>mast</b> <b>cells</b> were markedly increased, but white cells decreased with increase in <b>mast</b> cell: white <b>cell</b> ratio, and they were propelled in the recovery after injection. It was, by the results described above, concluded that the <b>mast</b> <b>cells</b> were definitely increased after injection of cancer extract...|$|R
40|$|In this study, we {{compared}} hematopoietic stem <b>cells</b> and <b>mast</b> <b>cells,</b> using microarray expression analysis, and identified the cellular prion protein (PrPC) as a potentially novel marker of <b>mast</b> <b>cells.</b> On further investigation, {{we found that}} PrPC is expressed {{on the surface of}} human and mouse <b>mast</b> <b>cells,</b> is rapidly released by <b>mast</b> <b>cells</b> upon activation, and is re-leased in response to mast cell–dependent allergic inflam-mation in vivo. Because <b>mast</b> <b>cells</b> are long lived and traffic to the brain and central nervous system, our observations could have important implications for the transmission and pathology of prion diseases. <b>Mast</b> <b>cells</b> are highly granular immune effector cells that de-velop from hematopoietic stem cells (HSCs), circulate as com-mitted precursors, and mature in their target tissues. <b>Mast</b> <b>cells</b> are located in many tissues, including the skin, gut, brain, an...|$|R
25|$|There are {{hypersensitivity}} responses, both a type I response (atopic, with {{formation of}} immunoglobulin E, or IgE) and a type III hypersensitivity response (with formation of immunoglobulin G, or IgG). The reaction of IgE with Aspergillus antigens results in <b>mast</b> <b>cell</b> degranulation with bronchoconstriction and increased capillary permeability. Immune complexes (a type III reaction) and inflammatory cells are deposited within the mucous membranes of the airways, leading to necrosis (tissue death) and eosinophilic infiltration. Type 2 T helper cells appear {{to play an}} important role in ABPA due to an increased sensitivity to interleukin (IL) 4 and IL-5. These cytokines up-regulate <b>mast</b> <b>cell</b> degranulation, exacerbating respiratory decline.|$|E
25|$|Viral {{conjunctivitis}} usually resolves {{on its own}} {{and does}} not require any specific treatment. Antihistamines (e.g., diphenhydramine) or <b>mast</b> <b>cell</b> stabilizers (e.g., cromolyn) {{may be used to}} help with the symptoms. Povidone iodine has been suggested as a treatment, but as of 2008 evidence to support it was poor.|$|E
25|$|Sexual {{activity}} {{for the first}} time may set the stage for an associated asthma attack or may aggravate pre-existing asthma. Intense emotional stimuli during sexual intercourse can lead to autonomic imbalance with parasympathetic over reactivity, thereby causing release of <b>mast</b> <b>cell</b> mediators that can provoke postcoital asthma and / or rhinitis in these patients.|$|E
40|$|Angiogenesis is {{a complex}} process that {{involves}} interactions between endothelial cells and various other cell types {{as well as the}} tissue microenvironment. Several previous studies have demonstrated that <b>mast</b> <b>cells</b> accumulate at angiogenic sites. In spite of the evidence suggesting a relationship between <b>mast</b> <b>cells</b> and angiogenesis, the association of <b>mast</b> <b>cells</b> and endothelial cells remains poorly understood. The present study aims to investigate the relationship between <b>mast</b> <b>cells</b> and endothelial cells during in vitro angiogenesis. When endothelial cells were co-cultured with <b>mast</b> <b>cells,</b> angiogenesis was stimulated. Furthermore, there was direct intercellular communication via gap junctions between the two cell types. In addition, the presence of <b>mast</b> <b>cells</b> stimulated endothelial cells to release angiogenic factors. Moreover, conditioned medium from the co-cultures also stimulated in vitro angiogenesis. The results from this investigation demonstrate that <b>mast</b> <b>cells</b> have both direct and indirect proangiogenic effects and provide new insights into the role of <b>mast</b> <b>cells</b> in angiogenesis...|$|R
40|$|A {{panel of}} rat {{monoclonal}} antibodies {{was used to}} classify mouse <b>mast</b> <b>cells</b> from four different sources {{on the basis of}} their surface determinants. Three populations of <b>mast</b> <b>cells</b> were derived by culturing normal bone marrow, spleen, and peripheral blood cells, whereas the fourth population was isolated directly from the peritoneal cavity. For each population, a surface antigen phenotype was determined by indirect immunofluorescence microscopy and compared to the phenotypes of the other populations of <b>mast</b> <b>cells.</b> The results showed that culture-derived <b>mast</b> <b>cells,</b> regardless of origin, had nearly identical antigen phenotypes, suggesting that these populations were comparable. By contrast, peritoneal <b>mast</b> <b>cells</b> had a different phenotype, suggesting that they represented a class distinct from culture-derived <b>mast</b> <b>cells.</b> These findings, which corroborate classification schemes based on nonimmunologic methods, demonstrate that subpopulations of mouse <b>mast</b> <b>cells</b> can be distinguished antigenically...|$|R
40|$|Cutaneous <b>mast</b> <b>cells</b> from 3 {{patients}} with mastocytosis were evaluated for their morphologic characteristics and in vitro functional reactivities to different secretory agonists. By electron microscopy, mastocytosis <b>mast</b> <b>cells</b> appeared larger than normal skin <b>mast</b> <b>cells,</b> frequently had atypical, highly indented or bibbed nuclei, and each contained numerous, elongated cytoplasmic projections. Suspensions of mastocytosis <b>mast</b> <b>cells</b> {{were obtained from}} lesional skin biopsy specimens, and their response to both immunologic and nonimmunologic secretagogues was compared with <b>mast</b> <b>cells</b> from normal skin. Lesional skin <b>mast</b> <b>cells</b> had a net histamine release of 12. 3 % (± 1. 3 SEM) and 31. 1 % (± 6. 0 SEM) following stimulation with the purified human anaphylotoxin C 3 a and mouse monoclonal antihuman IgE antibodies, respectively. This specific release {{was similar to the}} responses observed in normal skin <b>mast</b> <b>cells</b> (11. 5 % ± 4. 5 SEM and 16. 7 % ± 2. 1 SEM, respectively. <b>Mast</b> <b>cells</b> from cutaneous lesions of mastocytosis also responded to the nonimmunologic secretagogues, morphine sulfate and calcium ionophore A 23187 with a specific histamine release of 15. I% (± 1. 2 SEM) and 39. 8 % (± 8. 7 SEM), respectively. The results of this study demonstrate that <b>mast</b> <b>cells</b> from lesions of mastocytosis are morphologically atypical, but have a histamine content similar to normal skin <b>mast</b> <b>cells</b> and retain their functional reactivities to clinically relevant secretory stimuli...|$|R
25|$|Prevention {{is partly}} by handwashing. Treatment {{depends on the}} {{underlying}} cause. In the majority of viral cases, there is no specific treatment. Most cases due to a bacterial infection will also resolve without treatment; however, antibiotics can shorten the illness. Those who wear contact lens and those with either gonorrhea or chlamydia as the cause should be treated. Allergic cases can be treated with antihistamine or <b>mast</b> <b>cell</b> inhibitor drops.|$|E
25|$|Ocular tumors* in {{dogs are}} found in the eyelid, conjunctiva, third eyelid, cornea, sclera, iris, ciliary body, retina, choroid, optic nerve, and orbit. The most common types are Meibomian gland adenoma (eyelid), {{papilloma}} (eyelid), melanoma (eyelid, conjunctiva, sclera, iris, ciliary body, choroid), squamous cell carcinoma (conjunctiva), adenoma (ciliary body), adenocarcinoma (ciliary body), lymphoma (retina, choroid, ciliary body), medulloepithelioma (retina, choroid), ganglioglioma (retina, choroid), osteosarcoma (orbit), <b>mast</b> <b>cell</b> tumor (orbit), and optic nerve sheath meningioma.|$|E
25|$|Several {{medications}} {{may be used}} {{to block}} the action of allergic mediators, or to prevent activation of cells and degranulation processes. These include antihistamines, glucocorticoids, epinephrine (adrenaline), <b>mast</b> <b>cell</b> stabilizers, and antileukotriene agents are common treatments of allergic diseases. Anti-cholinergics, decongestants, and other compounds thought to impair eosinophil chemotaxis, are also commonly used. Though rare, the severity of anaphylaxis often requires epinephrine injection, and where medical care is unavailable, a device known as an epinephrine autoinjector may be used.|$|E
40|$|<b>Mast</b> <b>cells</b> are {{important}} immune cells for host defense through activation of innate immunity (via toll-like receptors or complement receptors) and acquired immunity (via FcεRI). Conversely, <b>mast</b> <b>cells</b> also act as effector cells that exacerbate development of allergic or autoimmune disorders. Yet, several lines of evidence show that <b>mast</b> <b>cells</b> act as regulatory cells to suppress certain inflammatory diseases. Here, we review the {{mechanisms by which}} <b>mast</b> <b>cells</b> suppress diseases...|$|R
40|$|The {{prevalence}} of <b>mast</b> <b>cells</b> infiltrating bone marrow of different rats varied widely, {{as did the}} staining properties and size of their cytoplasmic granules. Bone marrow <b>mast</b> <b>cells</b> from several rats revealed large membrane-limited inclusions which stained metachromatically or orthochromatically and resembled inclusions in some macrophages. Ultrastructurally, <b>mast</b> <b>cells</b> varied widely in content of uniform dense granules or enlarged granules with less dense, fine grained content. Some of the large inclusions observed ultrastructurally in <b>mast</b> <b>cells</b> were heterophagic vacuoles which contained erythrocytes or reticulocytes, or remnants from other phagocytized cells, possibly neutrophils or unidentified homogeneous material. Smaller bodies, interpreted as fragments of erythrocytes, lay extracellularly near <b>mast</b> <b>cells</b> and occupied small, membrane-limited, heterophagic vacuoles in some <b>mast</b> <b>cells.</b> In other <b>mast</b> <b>cells,</b> communal vacuoles enclosed several specific cytoplasmic granules {{in various stages of}} disruption. The communal vacuoles occasionally opened to the extracellular space. A few large indeterminate vacuoles in <b>mast</b> <b>cells</b> contained amorphous flocculent matter which apparently derived either from coalescence of cytoplasmic granules through fusion of granule membranes or from endocytosis...|$|R
40|$|AbstractThe {{purpose of}} this review is to discuss the role of <b>mast</b> <b>cells</b> in {{allergic}} inflammation. We have focused on inflammation associated with allergic asthma and food allergy. <b>Mast</b> <b>cells</b> are ‘first line of defense’ innate/adaptive immune cells and are widely distributed in tissues in surfaces exposed to the environment. Especially in allergic settings <b>mast</b> <b>cells</b> are extensively studied, {{as they can be}} activated to release a wide range of mediators by allergen-IgE specific triggers. In addition, in allergic inflammation <b>mast</b> <b>cells</b> can also be activated non-allergic triggers. Recent studies revealed that <b>mast</b> <b>cells,</b> besides the classical role of pro-inflammatory effector cell, have also emerged as modulators of allergic sensitization and down-regulators of allergic inflammation. Therefore, <b>mast</b> <b>cells</b> can be regarded as ‘Ying Yan’ modulators in allergic responses in intestinal tract and airways. This article is part of a Special Issue entitled: <b>Mast</b> <b>Cells</b> in Inflammation...|$|R
25|$|According to a UK Kennel Club health survey, cancer {{accounts}} for 38.5% of Boxer deaths, followed by old age (21.5%), cardiac (6.9%) and gastrointestinal (6.9%) related issues. The breed is particularly predisposed to <b>mast</b> <b>cell</b> tumours, a {{cancer of the}} immune system. Median lifespan was 10.25 years. Responsible breeders use available tests to screen their breeding stock before breeding, {{and in some cases}} throughout the life of the dog, in an attempt to minimize the occurrence of these diseases in future generations.|$|E
25|$|The {{diagnosis}} is {{made on the}} clinical picture. Routine blood tests (complete blood count, electrolytes, renal function, liver enzymes) are typically performed. <b>Mast</b> <b>cell</b> tryptase levels may be elevated if the attack was due to an acute allergic (anaphylactic) reaction. When the patient has been stabilized, particular investigations may clarify the exact cause; complement levels, especially depletion of complement factors 2 and 4, may indicate deficiency of C1-inhibitor. HAE type III is a diagnosis of exclusion consisting of observed angioedema along with normal C1 levels and function.|$|E
25|$|Currently, {{allergic}} {{diseases and}} asthma are usually treated {{with one or}} more of the following drugs: (1) antihistamines and antileukotrienes, which antagonize the inflammatory mediators histamine and leukotrienes, (2) local or systemic (oral or injectable) corticosteroids, which suppress a broad spectrum of inflammatory mechanisms, (3) short or long-acting bronchodilators, which relax smooth muscle of constricted airway in asthma, or (4) <b>mast</b> <b>cell</b> stabilizers, which inhibit the degranulation of mast cells that is normally triggered by IgE-binding at FcεRI. Long-term uses of systemic corticosteroids are known to cause many serious side effects and are advisable to avoid, if alternative therapies are available.|$|E
40|$|ABSTRACTThe {{allergenic}} {{activity of}} 60 kDa antigen of Brugia malayi adult worm, {{due to its}} ability to release histamine from <b>mast</b> <b>cells,</b> has been previously reported by us. To determine the roles of protein kinase C (PKC) and calmodulin in this process, histamine release from passively sensitized lung and peritoneal <b>mast</b> <b>cells</b> was investigated {{in the presence of}} W- 7 and trifluoperazine, used as calmodulin inhibitors, and H- 7, used as a PKC inhibitor. The results show that H- 7 is able to inhibit histamine release from both lung and peritoneal <b>mast</b> <b>cells,</b> thus suggesting a vital role of PKC in histamine release. However, lung and peritoneal <b>mast</b> <b>cells</b> exhibited a differential response to the calmodulin inhibitors. The calmodulin inhibitors prevented histamine release from peritoneal <b>mast</b> <b>cells,</b> but not from lung <b>mast</b> <b>cells,</b> thus suggesting that calmodulin is not essential for histamine release by lung <b>mast</b> <b>cells...</b>|$|R
40|$|The {{presence}} of chymase-like proteinase in bovine <b>mast</b> <b>cells</b> was investigated by an enzyme-histochemical technique (naphthol-AS-D-chloroacetate as substrate) in normal skin, primary bronchus, lung and duodenum. The counts {{and distribution of}} chymase-positive and toluidine blue-positive <b>mast</b> <b>cells</b> were compared by means of successive staining. <b>Mast</b> <b>cells</b> with chymase-like activity were detected in all areas, but their proportion was greater in connective than mucosal tissues, {{with the exception of}} the skin. These results contrast with those obtained in rodents, in which chymase-like proteinases are detected in all tissues and also in all <b>mast</b> <b>cells.</b> Bovine <b>mast</b> <b>cells</b> are closer to those of human beings, in which chymase-containing <b>mast</b> <b>cells</b> predominate in connective tissues, including skin. The results suggest that more than one chymase subset is present, at least in duodenum. The possible occurrence of dual-specific chymase <b>mast</b> <b>cells,</b> as in other ruminants, is discussed. Peer reviewe...|$|R
40|$|The {{function}} of <b>mast</b> <b>cells</b> in allergic inflammatory reactions {{is well documented}} in the literature. <b>Mast</b> <b>cells</b> also {{play an important role}} in the regulation of gastrointestinal visceral sensitivity and vascular permeability. Several studies have noted an increased number of <b>mast</b> <b>cells</b> in the mucosa of patients with gastrointestinal diseases such as irritable bowel syndrome, mastocytic enterocolitis, and systemic mastocytosis. The role of <b>mast</b> <b>cells</b> in the symptomatology of these and other diseases has only recently been fully appreciated and could provide avenues for new therapeutic opportunities. This paper examines studies that have evaluated the role of <b>mast</b> <b>cells</b> in various gastrointestinal diseases...|$|R
